Skip to content

Evaluation of a Multidisciplinary Lifestyle Treatment for Inpatients With Mental Illness

Evaluation of the Implementation and Effectiveness of a Multidisciplinary Lifestyle Treatment for Inpatients With Mental Illness (MULTI+)

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04922749
Acronym
MULTI+
Enrollment
846
Registered
2021-06-11
Start date
2020-07-01
Completion date
2022-09-01
Last updated
2021-11-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lifestyle, Mental Illness

Keywords

Inpatients, Implementation

Brief summary

People with mental illness (MI) have a reduced life expectancy compared to the general population, mostly attributable to somatic diseases caused by poor physical health. Modifiable lifestyle factors have been increasingly associated with the onset of somatic diseases in people with MI and refer to health behaviours such as physical activity (PA), diet, sleep and smoking behaviour. Despite the evidence demonstrating the efficacy of interventions aimed at improving lifestyle factors, there have not been many structural changes in routine clinical care for people with MI. Using a multidisciplinary, multicomponent approach, Deenik and colleagues (2019) were the first to find long-term positive effects in both mental and somatic health in a real-world inpatient setting for people with severe mental illness (SMI). They found improvements in metabolic health, psychosocial functioning and quality of life, and a reduction in the use of psychotropic medication. The authors urged to confirm and complement findings in scaled-up studies, and made several suggestions for improvement of the treatment and pragmatic research of implementation. In line with these previous recommendations the MULTI is being scaled-up into the MULTI+. This study investigates the implementation and effectiveness of a multidisciplinary lifestyle treatment for inpatients with mental illness (MULTI+).

Detailed description

Study design and setting This study is a prospective open cohort stepped wedge cluster randomized trial with continuous recruitment. This study is being conducted at the inpatient psychiatric wards, covering approximately 750 places of residency in which approximately 2000 patients are treated annually, from the specialist mental healthcare organisation GGz Centraal (the Netherlands). The study uses a stepped-wedge clustered design. The psychiatric wards are divided into three clusters, based on their geographical locations. These clusters gradually implement MULTI+ in semi-annual steps, such that all clusters are exposed to the MULTI+ at the end of the study. The repeated measurements are conducted on ward-level, rather than individual patient level. Intervention MULTI+ is a multidisciplinary, multicomponent treatment which aims to improve lifestyle factors through a holistic lifestyle approach, by focusing on 10 core components. Core components refer to essential elements and activities that are necessary to achieve desired outcomes. The core components of MULTI+ are based on previous recommendations and existing literature. The core components of MULTI+ are routine daily structure and sleep, physical activity, attention to nutrition and eating habits, smoking cessation, multidisciplinary treatment, skills training, psychoeducation, critical review of obesogenic environment and existing policies, active participation of health care professionals (HCPs), and training of HCPs. The core components are co-designed and tailored to the ward and patient population, because of the large heterogeneity in patient characteristics and varying access to facilities and staffing. Analyses To measure the intervention effect, linear mixed models will be used for continuous outcome measures and logistic mixed models for dichotomous outcome measures. In each model, the intervention effect will be estimated as the difference between the postintervention and preintervention levels of the outcome after adjusting for time as a categorical variable. All models will be corrected for group differences at baseline and the baseline differences of the outcome measures concerned (to account for regression to the mean).

Interventions

BEHAVIORALMULTI+

MULTI+ is a multidisciplinary, multicomponent treatment which aims to improve lifestyle factors through a holistic lifestyle approach, by focusing on 10 core components. The MULTI+ will be integrated into daily treatment to promote uptake and sustainability.

Sponsors

Stichting tot steun VCVGZ
CollaboratorOTHER
UMC Utrecht
CollaboratorOTHER
Maastricht University
CollaboratorOTHER
The Healthcare Innovation Centre
CollaboratorUNKNOWN
GGZ Centraal
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Prospective open cohort stepped wedge cluster randomized trial

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 16 years or older * Mentally ill inpatients * Receive care at the inpatient psychiatric wards of GGz Centraal where the MULTI+ will be implemented

Exclusion criteria

* Limited knowledge or understanding of Dutch * If their psychiatric or physical condition hinders informed consent at the discretion of the relevant physician, nurses, or researcher

Design outcomes

Primary

MeasureTime frameDescription
QRISK3 score4 measurements semi-annually over a period of 24 monthsAlgorithm that estimates the probability of developing cardiovascular disease over the next 10 years by taking multiple risk factors into account.

Secondary

MeasureTime frameDescription
Change in metabolic health: Waist circumference4 measurements semi-annually over a period of 24 monthswaist circumference measured halfway between the iliac crest and lowest rib in standing position
Change in metabolic health: Systolic and diastolic blood pressure4 measurements semi-annually over a period of 24 monthsMeasured systolic and diastolic blood pressure (mmHg)
Change in metabolic Health:Lipids4 measurements semi-annually over a period of 24 monthsValues in blood sample
Change in metabolic Health: HDL Cholesterol4 measurements semi-annually over a period of 24 monthsValues in blood sample
Change in metabolic Health: triglycerides4 measurements semi-annually over a period of 24 monthsValues in blood sample
Change in metabolic Health: Fasting glucose4 measurements semi-annually over a period of 24 monthsValues in blood sample
Weight Change4 measurements semi-annually over a period of 24 monthsWeight is measured to the nearest 0.1 kg.
Change in BMI4 measurements semi-annually over a period of 24 monthsweight divided by height in meters squared
Change in medication use through daily defined doses (DDD)4 measurements semi-annually over a period of 24 monthsMedication prescribed for cardiovascular health and diabetes, and psychotropic medication will be converted into daily defined doses (DDD) according the Anatomical Therapeutic Chemical Classification System from the World Health Organization (WHO). Medication data is obtained from patient files.
Change in psychosocial functioning: Adults4 measurements semi-annually over a period of 24 monthsMeasured by the Health of the Nations Outcomes Scale (HoNOS-12). All items are scored on a 5-point Likert scale, ranging from 0 (no problem) to 4 (severe problem).
Change in psychosocial functioning: Elderly4 measurements semi-annually over a period of 24 monthsMeasured by the Health of the Nations Outcomes Scale (HoNOS-65+). All items are scored on a 5-point Likert scale, ranging from 0 (no problem) to 4 (severe problem).
Change in psychosocial functioning: Adolescents4 measurements semi-annually over a period of 24 monthsMeasured by the Health of the Nations Outcomes Scale (HoNOSCA). All items are scored on a 5-point Likert scale, ranging from 0 (no problem) to 4 (severe problem).
Change in substance use4 measurements semi-annually over a period of 24 monthsMeasured by routine questions about smoking, alcohol use and soft drugs
Change in dietary habits4 measurements semi-annually over a period of 24 monthsMeasured by the Three Factor Eating Questionnaire Revised 18-items (TFEQ-R18), which consists of 18 items on a 4 point measuring scale, measuring cognitive restraint, uncontrolled eating and emotional eating. Raw scale scores are transformed on a scale from 0-100 (raw score- lowest possible score/possible raw score range)\*100).
Change in physical activity (PA): PaVs4 measurements semi-annually over a period of 24 monthsMeasured by the physical activity vital sign (PaVs). The PaVs is a two-item questionnaire, recommended as a brief way to routinely gain insight in physical activity levels. The PaVs can be used to assess whether the national activity guideline for aerobic activity are met in the context of health considerations (yes = 1, no = 0). Higher score means that the national activity guidelines are met.
Change in physical activity (PA): SIMPAQ4 measurements semi-annually over a period of 24 monthsMeasure by the Simple Physical activity Questionnaire (SIMPAQ). The SIMPAQ consists of five items (boxes), and participants are asked about time spent in bed (box 1), time sedentary, including naps (box 2), time spent walking (box 3), time spent exercising (box 4) and time spent in incidental activity, such as housekeeping (box 5). The total self-reported time spent on moderate-vigorous physical activity (MVPA) can be calculated by adding box 4 and 5.
Change in sleep (SCOPA-sleep)4 measurements semi-annually over a period of 24 monthsMeasured by the Scales for Outcomes in Parkinson's Disease - Sleep (SCOPA-Sleep). The SCOPA-Sleep is developed to evaluate night-time sleep and daytime sleepiness in a short and practical manner. The questionnaire enquires about the use of sleep medication and if so, which medication. It then uses 5 items to evaluate night-time sleep, 1 question inquiring overall quality of sleep followed by 6 items to evaluate daytime sleepiness on a 4 point Likert scale ranging from 0 (not at all) to 4 (a lot).
Change in psychopathology (BSI)4 measurements semi-annually over a period of 24 monthsMeasured by the Brief Symptom Inventory (BSI). The BSI comprises 53 items that reflect 9 symptom domains of psychopathology (somatization, obsessive compulsive, interpersonal sensitivity, depression, anxiety, hostility, phobic anxiety, paranoid ideation and psychoticism). Each item is rated on a 5-point scale of distress from 0 (not at all) to 4 (extremely).
Change in Quality of life (WHOQoL-Bref)4 measurements semi-annually over a period of 24 monthsMeasured by the World Health Organisation Quality of Life-BREF (WHOQoL-BREF). The four WHOQoL-BREF domains are measured through 24 domain-specific items: Physical health (7 items), Psychological (6 items), Social relations (3 items) and Environment (8 items) and two general health items. Item scores have various options but always range from 1 to 5, such as very poor to very good or not at all to extremely, and will be converted to domain scores (range from 4 to 20) based on the WHO guidelines. Higher score reflect a better quality of life.
Change in Quality of life (EQ-5D)4 measurements semi-annually over a period of 24 monthsMeasured by the EuroQol 5D (EQ-5D).The EQ-5D is a generic instrument that consists of 5 dimensions of health, with one item per dimension; mobility, selfcare, usual activities, pain/discomfort, and anxiety/depression. There are three levels of severity ranging from no issues to many issues. The index score are calculated ranging from 0 (worst quality of life) to 1 (perfect quality of life).
Change in meaning in life (MHC-SF)4 measurements semi-annually over a period of 24 monthsMeasured by the Mental Health Continuum - Short Form (MHC-SF). The MHC-SF measures positive mental health and consists of 14 items, representing feelings of well-being: Emotional well-being (three items), Psychological well-being (six items), and Social well-being (five items). Participants rate the frequency of these feelings in the past month on a 6-point Likert scale (never, once or twice a month, about once a week, two or three times a week, almost every day, every day).
Barriers and facilitators of the implementation of the MULTI+ (MIDI)4 measurements semi-annually over a period of 24 monthsMeasured by the Measurement Instrument for Determinants of the Innovation (MIDI). The MIDI is comprised of 28 items, divided into 4 scales measuring determinants associated with innovations (7 items), the user (11 items) and the organization (10 items). All items are scored on a 5-point Likert scale ranging from 1 (totally disagree) to 5 (totally agree). Items which ≥20% responds negatively (disagree/totally disagree) are considered barriers. Items which ≥80% respond positively (agree/totally agree) are considered facilitators.
Change in amount of adverse events24 monthsInstitutional software in which employees register and categorize adverse events (e.g. aggression).
Change in motivation for behavioural regulation for physical activity4 measurements semi-annually over a period of 24 monthsMeasured by the Behavioural Regulation in Exercise Questionnaire (BREQ-2). The BREQ-2 is comprised of 19 items, divided into 5 scales measuring; Amotivation (item 5, 9 12, 19), External (item 1, 6, 11, 16), Identified (item 2, 7, 13), Introjected (item 3, 8, 14, 17), and Intrinsic (item 4, 10, 15, 18 ) regulations. The mean scores for each scale can be used as a multidimensional instrument, giving separate scores for each subscale.
Change in motivation for behavioural regulation for healthy diet4 measurements semi-annually over a period of 24 monthsBased on the BREQ-2 as used in this study, the researchers devised a behavioural regulation diet questionnaire. All mentioning of exercise in the BREQ-2 has been replaced by referring to (eat a) healthy diet. This questionnaire comprised of 19 items, divided into 5 scales measuring; Amotivation (item 5, 9 12, 19), External (item 1, 6, 11, 16), Identified (item 2, 7, 13), Introjected (item 3, 8, 14, 17), and Intrinsic (item 4, 10, 15, 18 ) regulations. The mean scores for each scale can be used as a multidimensional instrument, giving separate scores for each subscale.
Health Technology Assessment (HTA)24 monthsCost-effectiveness will be investigated through calculation of the costs of treatment as usual as compared to costs of MULTI+
Change in diet4 measurements semi-annually over a period of 24 monthsMeasured by a 24-hour dietary recall (24HR)

Other

MeasureTime frameDescription
Process evaluation - Change in RE-AIM domains24 monthsThe process evaluation is conducted using the RE-AIM framework (RE-AIM). Reach, Efficacy, Adoption, Implementation and Maintenance will be assessed continuously throughout the study. There are no scores attached to the domains, rather, change is evaluated.

Countries

Netherlands

Contacts

Primary ContactJeroen Deenik, Dr.
j.deenik@ggzcentraal.nl+31622049524
Backup ContactMyrthe van Schothorst, MSc
m.vanschothorst@ggzcentraal.nl+3182648117

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026